IA
CYTK icon

IFP Advisors’s Cytokinetics CYTK Stock Holding History

IFP Advisors’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11K Sell
129
-377
-75% -$27.1K ﹤0.01% 3336
2026
Q1 		$33.4K Hold
506
– – ﹤0.01% 2482
2025
Q4 		$32.2K Buy
506
+48
+10% +$2.99K ﹤0.01% 2449
2025
Q3 		$25.2K Buy
458
+147
+47% +$6.06K ﹤0.01% 2466
2025
Q2 		$20.5K Buy
311
+68
+28% +$2.37K ﹤0.01% 2532
2025
Q1 		$9.77K Sell
243
-2
-0.8% -$92 ﹤0.01% 2588
2024
Q4 		$11.5K Sell
245
-25
-9% -$1.3K ﹤0.01% 2473
2024
Q3 		$14.3K Buy
270
+10
+4% +$557 ﹤0.01% 2294
2024
Q2 		$14.1K Buy
260
+243
+1,429% +$14.7K ﹤0.01% 2218
2024
Q1 		$1.19K Buy
+17
New +$1.31K ﹤0.01% 2823
2023
Q1 		– Sell
-10
Closed -$1K – 3595
2022
Q4 		$1K Sell
10
-1,002
-99% -$43.1K ﹤0.01% 4313
2022
Q3 		$10K Hold
1,012
– – ﹤0.01% 3626
2022
Q2 		$10K Hold
1,012
– – ﹤0.01% 3386
2022
Q1 		$10K Buy
1,012
+999
+7,685% +$35.5K ﹤0.01% 3386
2021
Q4 		$1K Hold
13
– – ﹤0.01% 2973
2021
Q3 		$1K Sell
13
-2
-13% -$59 ﹤0.01% 3006
2021
Q2 		$0 Sell
15
-39
-72% -$916 ﹤0.01% 3094
2021
Q1 		$1K Sell
54
-14
-21% -$299 ﹤0.01% 2808
2020
Q4 		$1K Buy
+68
New +$1.24K ﹤0.01% 2741
2016
Q1 		– Sell
-2,700
Closed -$28K – 2578
2015
Q4 		$28K Buy
+2,700
New +$26.5K ﹤0.01% 1962

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IFP Advisors's CYTK Position: Q2 2026 in Review

IFP Advisors reduced its Cytokinetics (CYTK) stake by 75% in Q2 2026, selling an estimated $27.1K and leaving 129 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #3336.

IFP Advisors first reported a position in CYTK in Q4 2015 and has held it in 20 quarters since. The position peaked at $33.4K in Q1 2026. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • IFP Advisors held 129 shares of Cytokinetics worth $11K as of Q2 2026.
  • IFP Advisors sold 377 Cytokinetics shares in Q2 2026, an estimated $27.1K.
  • Cytokinetics made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3336 holding.
  • IFP Advisors first reported a position in Cytokinetics in Q4 2015 and has held it in 20 quarters since.
  • IFP Advisors's Cytokinetics position peaked at $33.4K in Q1 2026.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.